M&A Deal Summary

Symbio Proinnovera Acquires Proinnovera

On November 17, 2023, Symbio Proinnovera acquired life science company Proinnovera

Acquisition Highlights

This is Symbio Proinnovera’s 1st transaction in the Life Science sector.
This is Symbio Proinnovera’s 1st transaction in Germany.

M&A Deal Summary
Date	2023-11-17
Target	Proinnovera
Sector	Life Science
Buyer(s)	Symbio Proinnovera
Deal Type	Merger

Target

Proinnovera

Münster, Germany

Proinnovera is a full-service CRO conducting clinical studies from Phase I to IV, as well as non-interventional and medical device studies. Proinnovera turns study data into oversight for clients to accelerate decision-making, increasing transparency and efficiency in the conduct of clinical trials. Both companies are proven market leaders among specialty dermatology CROs with exceptional geographical coverage. Proinnovera was formed in 1997 and is based in Münster, Germany.

Search 214,238 Deals Now

SEARCH BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Try Free

Buyer(S) 1

Buyer